We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
Cap. Flow
-$695M
Cap. Flow %
-0.92%
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$840M
2
DIS icon
Walt Disney
DIS
+$492M
3
BA icon
Boeing
BA
+$492M
4
SBUX icon
Starbucks
SBUX
+$276M
5
SLB icon
SLB Ltd
SLB
+$216M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Consumer Discretionary 16.31%
3 Communication Services 13.43%
4 Healthcare 12.88%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JFR icon
426
Nuveen Floating Rate Income Fund
JFR
$1.26B
$2.07M ﹤0.01%
236,650
IVV icon
427
iShares Core S&P 500 ETF
IVV
$905B
$2.06M ﹤0.01%
5,500
NBIS
428
Nebius Group N.V.
NBIS
$49.1B
$2.02M ﹤0.01%
29,016
+11,622
+67% +$742K
BAP icon
429
Credicorp
BAP
$30.2B
$2M ﹤0.01%
12,191
+4,834
+66% +$671K
NKE icon
430
Nike
NKE
$61.2B
$2M ﹤0.01%
14,107
+10,758
+321% +$1.43M
CLB icon
431
Core Laboratories
CLB
$567M
$1.86M ﹤0.01%
70,004
+3,356
+5% +$68.5K
LRCX icon
432
Lam Research
LRCX
$395B
$1.71M ﹤0.01%
36,240
+1,600
+5% +$67.3K
ATVI
433
DELISTED
Activision Blizzard
ATVI
$1.61M ﹤0.01%
17,320
+4,511
+35% +$366K
DG icon
434
Dollar General
DG
$27B
$1.59M ﹤0.01%
7,561
+2,950
+64% +$630K
INTU icon
435
Intuit
INTU
$91.3B
$1.57M ﹤0.01%
4,133
+1,246
+43% +$438K
HCA icon
436
HCA Healthcare
HCA
$90B
$1.56M ﹤0.01%
9,502
+9,329
+5,392% +$1.36M
UAL icon
437
United Airlines
UAL
$40.7B
$1.55M ﹤0.01%
+35,904
New +$1.45M
TMO icon
438
Thermo Fisher Scientific
TMO
$222B
$1.55M ﹤0.01%
3,321
+2,732
+464% +$1.28M
LLY icon
439
Eli Lilly
LLY
$1.09T
$1.54M ﹤0.01%
9,125
+2,195
+32% +$328K
TGT icon
440
Target
TGT
$69.7B
$1.54M ﹤0.01%
8,731
+5,124
+142% +$855K
C icon
441
Citigroup
C
$228B
$1.53M ﹤0.01%
24,883
+3,889
+19% +$198K
IBM icon
442
IBM
IBM
$224B
$1.53M ﹤0.01%
12,720
-17
-0.1% -$1.97K
GEN icon
443
Gen Digital
GEN
$17.4B
$1.52M ﹤0.01%
73,362
+26,890
+58% +$543K
AMAT icon
444
Applied Materials
AMAT
$422B
$1.52M ﹤0.01%
17,609
+999
+6% +$73.8K
HUM icon
445
Humana
HUM
$45.5B
$1.52M ﹤0.01%
3,702
+1,138
+44% +$473K
PM icon
446
Philip Morris
PM
$289B
$1.51M ﹤0.01%
18,291
+4,662
+34% +$363K
MET icon
447
MetLife
MET
$61.6B
$1.5M ﹤0.01%
31,836
+6,322
+25% +$274K
LOW icon
448
Lowe's Companies
LOW
$125B
$1.46M ﹤0.01%
9,110
+2,105
+30% +$342K
MO icon
449
Altria Group
MO
$109B
$1.46M ﹤0.01%
35,487
+9,914
+39% +$398K
MAS icon
450
Masco
MAS
$14.9B
$1.44M ﹤0.01%
26,258
+9,468
+56% +$521K

Similar funds

Loomis, Sayles & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
  • Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
  • Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
  • Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
  • Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.